OAM
ABBV icon

Oak Asset Management’s AbbVie ABBV Stock Holding History

Oak Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.83M Buy
35,099
+30
+0.1% +$6.45K 2.84% 7
2026
Q1 		$7.63M Sell
35,069
-65
-0.2% -$14.4K 2.63% 8
2025
Q4 		$8.03M Sell
35,134
-1,179
-3% -$269K 2.74% 7
2025
Q3 		$8.41M Sell
36,313
-510
-1% -$104K 2.88% 9
2025
Q2 		$6.84M Sell
36,823
-185
-0.5% -$34.4K 2.45% 11
2025
Q1 		$7.75M Sell
37,008
-55
-0.1% -$10.7K 2.84% 7
2024
Q4 		$6.59M Sell
37,063
-425
-1% -$78.1K 2.44% 8
2024
Q3 		$7.4M Sell
37,488
-3,729
-9% -$696K 2.62% 7
2024
Q2 		$7.07M Sell
41,217
-330
-0.8% -$54.7K 2.59% 7
2024
Q1 		$7.57M Sell
41,547
-2,421
-6% -$417K 2.83% 6
2023
Q4 		$6.81M Sell
43,968
-739
-2% -$108K 2.71% 6
2023
Q3 		$6.66M Sell
44,707
-5,867
-12% -$861K 2.86% 5
2023
Q2 		$6.81M Sell
50,574
-286
-0.6% -$41.9K 2.82% 6
2023
Q1 		$8.11M Sell
50,860
-1,278
-2% -$195K 3.49% 5
2022
Q4 		$8.43M Sell
52,138
-737
-1% -$113K 3.78% 4
2022
Q3 		$7.1M Buy
+52,875
New +$7.59M 3.44% 6
2022
Q2 		– Sell
-52,630
Closed -$8.53M – 71
2022
Q1 		$8.53M Sell
52,630
-1,741
-3% -$253K 3.38% 5
2021
Q4 		$7.36M Sell
54,371
-170
-0.3% -$20.1K 2.81% 7
2021
Q3 		$5.86M Buy
54,541
+353
+0.7% +$40.3K 2.44% 8
2021
Q2 		$6.1M Buy
54,188
+128
+0.2% +$14.4K 2.57% 7
2021
Q1 		$5.85M Buy
54,060
+6,930
+15% +$741K 3.15% 7
2020
Q4 		$5.05M Sell
47,130
-111
-0.2% -$10.7K 2.46% 7
2020
Q3 		$3.98M Buy
47,241
+108
+0.2% +$10.2K 2.1% 13
2020
Q2 		$4.63M Buy
47,133
+1,007
+2% +$88.7K 2.74% 5
2020
Q1 		$3.51M Sell
46,126
-1,517
-3% -$129K 2.55% 6
2019
Q4 		$4.22M Sell
47,643
-895
-2% -$74.3K 2.35% 8
2019
Q3 		$3.67M Buy
48,538
+1,690
+4% +$116K 2.22% 9
2019
Q2 		$3.19M Buy
46,848
+1,258
+3% +$98.9K 1.98% 14
2019
Q1 		$3.67M Buy
45,590
+2,065
+5% +$169K 2.43% 8
2018
Q4 		$4.01M Buy
43,525
+85
+0.2% +$7.47K 2.97% 5
2018
Q3 		$4.11M Buy
43,440
+13,590
+46% +$1.29M 2.49% 7
2018
Q2 		$2.77M Sell
29,850
-150
-0.5% -$14.6K 1.89% 16
2018
Q1 		$2.84M Sell
30,000
-423
-1% -$46.5K 2.19% 14
2017
Q4 		$2.94M Buy
+30,423
New +$2.87M 2.24% 14

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Oak Asset Management's ABBV Position: Q2 2026 in Review

Oak Asset Management increased its AbbVie (ABBV) stake by 0.09% in Q2 2026, buying an estimated $6.45K and bringing the position to 35,099 shares worth $8.83M. The position accounts for 2.84% of the portfolio, ranked #7.

Oak Asset Management first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. 926 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Oak Asset Management held 35,099 shares of AbbVie worth $8.83M as of Q2 2026.
  • Oak Asset Management bought 30 AbbVie shares in Q2 2026, an estimated $6.45K.
  • AbbVie made up 2.84% of Oak Asset Management's portfolio in Q2 2026, its #7 holding.
  • Oak Asset Management first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
  • 926 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Oak Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.